BSG Highlights from US HUPO 2024 and MSACL 2024
Biotech Support Group exhibited at two recent conferences: the US Human Proteome Organization (US HUPO) 2024 Conference, March 9-13, 2024 in Portland, OR, and MSACL 2024 14th Annual Conference organized by the Association for Mass Spectrometry & Advances

News Release

BSG Highlights from US HUPO 2024 and MSACL 2024

MONMOUTH JUNCTION, NJ , April 5, 2024 -- Biotech Support Group exhibited at two recent conferences: the US Human Proteome Organization (US HUPO) 2024 Conference, March 9-13, 2024 in Portland, OR, and MSACL 2024 14th Annual Conference organized by the Association for Mass Spectrometry & Advances in the Clinical Lab (MSACL) March 17 - 22, 2024 in Monterey, CA. These conferences highlight the most recent advancements in Proteomics and Mass Spectrometry technology and applications, each with attendance of 400-500 scientists.

Featured at our Booth were our consumable sample prep products for Albumin & IgG removal, Hemoglobin removal, and new NRicher™ workflows to improve low abundance coverage, and targeted quantification of select sub-proteomics. In addition, we also presented a poster, entitled

"NRicher™ : Family Specific Enrichment For Targeted Proteomics"

Abstract The need for new biomarkers to support personalized healthcare, has fostered numerous proteomic innovations. Still, a number of challenges remain. One is the preponderance of high abundance proteins and, concurrently in targeted proteomic workflows, efficiency and consistency in quantifying target peptides from different sample cohorts. This is in part due to the changing landscape of proteins/peptides not associated with the selected targets. A solution for both these challenges is now available through a suite of products called NRicher™. This bead-based technology is derived from experience of over 10 years at the forefront of manufacturing beads (i.e., ionic, hydrophobic, hydrogen bonding, aromatic, polymeric) with differential proteome binding properties. NRicher™ consists of consumable chemically derived porous beads, and an adaptability to bead cocktails, even with seemingly incompatible surface features; an important distinction of porous, over non-porous magnetic beads. NRicher™ products do not require any specialized instruments, can be processed using a standard microfuge, with adaptability to automated liquid handlers.

BSG Highlights from US HUPO 2024 and MSACL 2024

Highlights

  • After NRicher , target peptides have enriched spectral signal, even as gradient times are reduced

  • NRicher sub-proteome enrichment can minimize acquisition time, collectively improving overall throughput, cost, and productivity

  • Investigate out of the Venn Diagram box. Specific target peptides that report functional and variant regions promise actionable insights and potential multiplex biomarkers for disease.

Click here to download poster

Click here for more information on all of our Albumin & IgG Removal products

Click here for more information on all of our Hemoglobin Removal products

Click here for more information on our NRicher™ products

Keywords: Albumin and IgG Removal, Hemoglobin Removal, Low Abundance Protein Enrichment, NRicher™

We had great feedback highlighting our many new product developments at these conferences. The NRicher™ series, is our next generation of products featuring all the combined beneficial attributes from our current products: they are all consumable, are species agnostic, have enriched sub-proteomes with functional integrity, and for LC-MS, digestion can be performed on-bead, without the use of detergents, for simplified and seamless workflows. It is very exciting to share these developments with industry leaders at the forefront of life science research”, states Dr. Swapan Roy, Ph.D., President and Founder of Biotech Support Group.

About Biotech Support Group LLC

Converging with cultural and technological disruptions forthcoming in healthcare, Biotech Support Group develops methods for cost effective and efficient sample prep essential for expanding proteomic analysis. Following a tiered business strategy, the company continues its growth in the consumable research products area. For this market, key products include: AlbuVoid™ and AlbuSorb™ PLUS for albumin & IgG depletion, Cleanascite ™ for lipid adsorption, HemogloBind™ and HemoVoid™ for hemoglobin removal, and NRicher™ for low abundance and family specific proteome enrichment. For more information, go to http://www.biotechsupportgroup.com

For business development contact: Matthew Kuruc
732-274-2866
mkuruc@biotechsupportgroup.com